IRDAI circular · 09 Oct 2018
• JI~ ~u<Jl~ .ftifi ~f.l~1¥tc¥ ~ m ~ ,,ot1:n INSURANCE REGULATORY AND ir.lai DEVELOPMENT AUTHORITY OF INDIA Ref: IRDA/HL T/MISC/CIR/16'1/10/2018 081h October, 2018 To All Insurers Re: The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and control) Act 2017 1. Reference is drawn to the…
• JI~ ~u<Jl~ .ftifi ~f.l~1¥tc¥ ~ m ~ ,,ot1:n INSURANCE REGULATORY AND ir.lai DEVELOPMENT AUTHORITY OF INDIA Ref: IRDA/HL T/MISC/CIR/16'1/10/2018 081h October, 2018 To All Insurers Re: The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and control) Act 2017 1. Reference is drawn to the Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act 2017 [HIV and AIDS (Prevention and Control) Act 2017]. 2. The provisions of the said Act have come into force with effect from 1 oth September 2018. 3. As per Sec 3U) of the said Act, (3)No person shall discriminate against the protected person on any ground including any of the following, namely: U) The denial of, or unfair treatment in, the provision of insurance unless supported by actuarial studies. 4. All insurance companies are hereby directed to comply with the aforesaid provisions of the HIV and AIDS (Prevention and Control) Act 2017 with immediate effect. Member (Non Life) ~ ;:j"_ 115/1,_ ~ ~ . 1wf,(l'l13: 1, ~-50~ 032, 'llT7i1 I Survey No. 115/1, Financial District, Nanakramguda, Hyderabad-500 032, India · +91-40-2020 4000 ~ : www.irda1.gov.1n Q) : +91-40-2020 4000 Website : www.irdai.gov.in